The Effectiveness and the Safety of Combined Tuberculosis Treatment Regimens Using the Drug Perchlozon. Methods of Forecasting, Prevention and Elimination of Adverse Events

Le résumé fourni par la source

The article presents the results of a randomized clinical trial to study the effectiveness of treatment of drug-resistant tuberculosis with the use of the anti-tuberculosis drug thioureidoiminomethylpyridinium perchlorate (Perchlozon, Tpp). The frequency of occurrence and the spectrum of adverse events studied. An in-depth analysis of individual adverse reactions and their causal relationship with various components of the combined treatment regimens carried out. Presented algorithms and recommendations for predicting, preventing, and correcting the most common complications of drug therapy.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.